An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial

By the PROTEKT Study Group   Massicotte P.   Julian J.A.   Gent M.   Shields K.   Marzinotto V.   Szechtman B.   Chan A.K.   Andrew M.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite

An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency

By              

AIDS Care, Vol. 26, Iss. 10, 2014-10 ,pp. : 1223-1228

Routledge Ltd

Access to resources Recommend Favorite

Late presentation for HIV care in central Haiti: factors limiting access to care

By Louis C.   Ivers L. C.   Fawzi M. C. Smith   Freedberg K. A.   Castro A.  

AIDS Care, Vol. 19, Iss. 4, 2007-04 ,pp. : 487-491

Routledge Ltd

Access to resources Recommend Favorite

Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High‐Fidelity Cardiovascular Phenotyping

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 1, 2016-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay

By Comanor L.   Elkin C.   Leung K.   Krajden M.   Kronquist K.   Nicolas K.   Horansky E.   deMedina M.   Kittichai P.   Sablon E.   Ziermann R.   Sherlock C.  

Journal of Clinical Virology, Vol. 28, Iss. 1, 2003-09 ,pp. : 14-26

Elsevier

Access to resources Recommend Favorite